Altered Endothelin-1 Signaling in Production of Thromboxane A2 in Kupffer Cells from Bile Duct Ligated Rats

被引:7
|
作者
Miller, Andrew M. [1 ,2 ]
Zhang, Jian X. [1 ]
机构
[1] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA
[2] NIAAA, Sect Liver Biol, Lab Physiol Studies, NIH, Bethesda, MD 20892 USA
关键词
Kupffer cell; endothelin-1; cytosolic phospholipase A(2); MAPK; TXA(2); bile duct ligation; CYTOSOLIC PHOSPHOLIPASE A(2); ARACHIDONIC-ACID RELEASE; ACTIVATED PROTEIN-KINASE; VASCULAR SMOOTH-MUSCLE; HAMSTER OVARY CELLS; BETA-GAMMA; ENHANCED EXPRESSION; GENE-EXPRESSION; C-DELTA; LIVER;
D O I
10.1038/cmi.2009.56
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Kupffer cells (KCs), the liver resident macrophages accounting for 80-90% of the total population of fixed tissue macrophages in the body, not only play a key role in host defense via removing particulate materials from the portal circulation, but may also contribute to the pathogenesis of various liver diseases. We have previously demonstrated that KCs play an important role in controlling portal hypertension and hepatocellular injury via releasing thromboxane A(2) (TXA(2)) in early fibrosis induced by one-week bile duct ligation (BDL). Production of TXA(2) is controlled by cytosolic phospholipase A(2) (cPLA(2)) that is activated by the interaction of entothelin-1 (ET-1) with its G-protein coupled ET receptor B (ETBR). However, the signaling pathways that contribute to the ET-1-induced activation of cPLA(2) and production of TXA(2) in KCs in the normal healthy or injured livers are not yet clear, which are investigated in the present study using isolated KCs from one-week BDL or sham rats. The pharmacological inhibition of cPLA(2) or chelation of intracellular calcium abrogated the ET-1 induction of TXA(2) from KCs. Compared to those from sham rats, KCs from BDL animals displayed a significantly enhanced responsiveness of p38 MAPK to ET-1, increased ETBR and G alpha i subunit but decreased G alpha q and G alpha 11 expression. Inhibition of ERK1/2 or Gq signaling abrogated significantly the ET-1 induction of TXA(2) in sham KCs but only slightly in BDL KCs. In contrast, inhibition of p38 MAPK and Gi signaling markedly attenuated the ET-1 induction of TXA(2) in BDL KCs but had no effect in sham KCs. Lastly, inhibition of PLC or PKC abrogated ET-1 induction of TXA(2) in KCs from both sham and BDL groups. The hepatic stress (such as BDL) induces significant modifications in the receptor and intermediates of ET-1 signaling in KC and subsequently alters ET-1 signaling mechanisms, particularly a shift from Gq induced signaling to Gi induced signaling, in the activation of cPLA(2) and production of TXA(2) in response to ET-1. Cellular & Molecular Immunology. 2009;6(6): 441-452.
引用
收藏
页码:441 / 452
页数:12
相关论文
共 50 条
  • [21] Role of thromboxane A2, endothelin-1 and endothelin-3 in rat nephrotoxic serum nephritis
    Zhou, LM
    Ida, T
    Marumo, F
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 178 (04): : 357 - 369
  • [22] Endothelin-1 Aggravates Hepatic Ischemia/Reperfusion Injury During Obstructive Cholestasis in Bile Duct Ligated Mice
    Nagai, Hiroyuki
    Kato, Atsushi
    Kimura, Fumio
    Shimizu, Hiroaki
    Yoshidome, Hiroyuki
    Ohtsuka, Masayuki
    Furukawa, Katsunori
    Nozawa, Satoshi
    Yoshitomi, Hideyuki
    Mitsuhashi, Noboru
    Takeuchi, Dan
    Suda, Kosuke
    Yoshioka, Isaku
    Miyazaki, Masaru
    JOURNAL OF SURGICAL RESEARCH, 2010, 162 (01) : 46 - 53
  • [23] Regulation of endothelin-1 production by a thromboxane A(2) mimetic in rat heart smooth muscle cells
    Chua, CC
    Hamdy, RC
    Chua, BHL
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1996, 1313 (01): : 1 - 5
  • [24] Altered release of endothelin-1,2 and thromboxane B-2 from trophoblastic cells in pre-eclampsia
    Cervar, M
    Kainer, F
    Jones, CJP
    Desoye, G
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1996, 26 (01) : 30 - 37
  • [25] Effects of oxidised LDL on nitric oxide and endothelin-1 production in human microvascular endothelium: Role of thromboxane A2 receptor
    Lubrano, V.
    Baldi, S.
    Ferranini, E.
    L'Abbate, A.
    Natali, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 40 - 40
  • [26] Losartan reduces constrictor responses to endothelin-1 and the thromboxane A2 analogue in aortic rings from spontaneously hypertensive rats:: role of nitric oxide
    Maeso, R
    Rodrigo, E
    Muñoz-García, R
    Navarro-Cid, J
    Ruilope, LM
    Lahera, V
    Cachofeiro, V
    JOURNAL OF HYPERTENSION, 1997, 15 (12) : 1677 - 1684
  • [27] Role of endothelin-1 and thromboxane A2 in renal vasoconstriction induced by angiotensin II in diabetes and hypertension
    Cediel, E
    Vázquez-Cruz, B
    Navarro-Cid, J
    De Las Heras, N
    Sanz-Rosa, D
    Cachofeiro, V
    Lahera, V
    KIDNEY INTERNATIONAL, 2002, 62 : S2 - S7
  • [28] Endothelin-1 and thromboxane A2 increase pulmonary vascular resistance in granulocyte-mediated lung injury
    Schmeck, J
    Janzen, R
    Münter, K
    Neuhof, H
    Koch, T
    Janzen, R
    CRITICAL CARE MEDICINE, 1998, 26 (11) : 1868 - 1874
  • [29] Combined blockade of endothelin-1 and thromboxane A2 receptors against postischaemic contractile dysfunction in rat hearts
    Hornstein, PS
    Zaugg, CE
    Zhu, PL
    Allegrini, PR
    Buser, PT
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (01) : 234 - 240
  • [30] Endothelin-1 releases endothelium derived endoperoxides and thromboxane A2 in porcine coronary arteries with regenerated endothelium
    Park, SJ
    Lee, JJ
    Vanhoutte, PM
    ACTA PHARMACOLOGICA SINICA, 1999, 20 (10): : 872 - 878